Thurston, Springer, Miller, Herd & Titak, Inc. Cv Rx, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $330 Million
- Q3 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Cv Rx, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 1,575 shares of CVRX stock, worth $21,199. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,575
Previous 1,925
18.18%
Holding current value
$21,199
Previous $23,000
43.48%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CVRX
# of Institutions
86Shares Held
14.4MCall Options Held
56.3KPut Options Held
41.8K-
Johnson & Johnson New Brunswick, NJ4.1MShares$55.2 Million11.52% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$31.9 Million1.6% of portfolio
-
Black Rock Inc. New York, NY876KShares$11.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$11.1 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT683KShares$9.19 Million0.85% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $277M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...